Genpact G Options forfeited/expired (in dollars per share)

Options forfeited/expired (in dollars per share) at other companies

TFS FinancialTFSL

$14.87-0.2%

Jazz PharmaceuticalsJAZZ

$167.80+12.6%

Baxter InternationalBAX

$54.86-15.9%

3MMMM

$167.20+27.8%

Coeur MiningCDE

$5.37-3.6%

International Business MachinesIBM

$166.00+16.1%

Other financials

Income statement

See full

Revenue$1.3B+6.7%

Gross profit$471.7M+9.9%

Operating income$198.6M+8.1%

Net income$148.0M+13.1%

EPS (diluted)$0.86+17.8%

Balance sheet

See full

Cash & equivalents$578.1M+2.9%

Total debt$1.4B-4.9%

Total equity$2.5B+0.9%

Total assets$5.6B+14.8%

Cash flow

See full

Operating cash flow-$23.5M-158%

CapEx$23.9M+8.9%

Free cash flow-$47.5M-357%

Valuation

See full

Market cap$4.79B-28.5%

Profitability

See full

Gross margin36.3%+0.8pp

Operating margin14.8%-0.1pp

Net margin11%+0.2pp

FCF margin13%+0.6pp

Returns & leverage

See full

Return on equity23.1%+0.9pp

Debt / equity0.6×0.0×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by Genpact in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice.

The official record: Genpact’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Genpact's options forfeited/expired (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Genpact's options forfeited/expired (in dollars per share)?: Genpact (G) reported options forfeited/expired (in dollars per share) of $0.00 in Q1 2026.